Загрузка...
Novel p53 therapies for head and neck cancer
Inactivation of the tumor suppressor p53 is the predominant pathogenetic event in head and neck squamous cell carcinoma (HNSCC). The p53 pathway in HNSCC can be compromised through multiple mechanisms including gene mutations, hyperactivation of endogenous negative p53 regulators and by the human pa...
Сохранить в:
| Опубликовано в: : | World J Otorhinolaryngol Head Neck Surg |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
KeAi Publishing
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698513/ https://ncbi.nlm.nih.gov/pubmed/29204550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.wjorl.2016.05.005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|